Jianmin Hu
Changsha, 410001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
HES1 deficiency impairs development of human intestinal mesenchyme by suppressing WNT5A expression.
Journal: Biochemical and biophysical research communications
Published: February 06, 2023
Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Journal: Signal transduction and targeted therapy
Published: December 20, 2022
Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum.
Journal: Theranostics
Published: June 06, 2022
Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1.
Journal: EMBO molecular medicine
Published: February 03, 2021
Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
Journal: Signal transduction and targeted therapy
Published: July 29, 2020
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication.
Journal: NPJ precision oncology
Published: July 01, 2020
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Journal: Theranostics
Published: March 14, 2020
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Journal: Signal transduction and targeted therapy
Published: January 17, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Journal: Molecular metabolism
Published: January 13, 2020
The Role of Deubiquitinases in Oncovirus and Host Interactions.
Journal: Journal of oncology
Published: March 11, 2019
Last Updated: 09/26/2026